Healthcare -
Biotechnology - NASDAQ - US
$ 0.2625
-3.42 %
$ 16.9 M
Market Cap
-0.44
P/E
GLYC - OPERATING EXPENSES
Operating Expenses GLYC - GlycoMimetics, Inc.
32.5 B
LAST VALUE
2516.71%
2 YEAR CAGR
250.58%
5 YEAR CAGR
103.90%
10 YEAR CAGR